← Back to Search

Lab-developed Test

Cohort 3 for Endometriosis

Phase 2
Recruiting
Led By Sandra M Hurtado, MD
Research Sponsored by Hera Biotech, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week after laparoscopy
Awards & highlights

Study Summary

This trial is testing a non-surgical way to diagnose endometriosis, by analyzing uterine tissue with lab + AI.

Eligible Conditions
  • Endometriosis
  • Diagnosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week after laparoscopy
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week after laparoscopy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Secondary outcome measures

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Cohort 3Experimental Treatment1 Intervention
Control--Not suspected of having and absence of endometriosis confirmed by diagnostic test. This group has uterine tissue biopsy and laparoscopy for non-endometriosis indication, i.e. tubal ligation
Group II: Cohort 2Active Control1 Intervention
Endometriosis diagnosed at stage 3 or 4
Group III: Cohort 1Active Control1 Intervention
Endometriosis diagnosed at stage 1 or 2

Find a Location

Who is running the clinical trial?

Hera Biotech, Inc.Lead Sponsor
Sandra M Hurtado, MDPrincipal InvestigatorUniversity of Texas Physicians Women's Center
Jacqueline A Robinson, MDPrincipal InvestigatorValley OB-GYN Clinic
~28 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top